Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1952 1
1953 1
1956 1
1957 3
1958 1
1982 1
1984 1
1986 1
1987 2
1988 1
1989 1
1991 2
1992 2
1993 1
1994 2
1997 1
1998 4
1999 4
2000 1
2005 1
2017 1
2018 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
[Side effects of hormonal contraception. Experiences with 1,702 patients and 17,228 cycles].
Hauser GA. Hauser GA. Geburtshilfe Frauenheilkd. 1987 Dec;47(12):859-63. doi: 10.1055/s-2008-1036062. Geburtshilfe Frauenheilkd. 1987. PMID: 2963781 German.
The genuine normophasic method showed generally a far better cycle control. Combining this method with a new gestagen (Desogestrel) resulted a still better cycle control, especially with amenorrhea. The events of nervosity, gastrointestinal disturbances, changes of libido …
The genuine normophasic method showed generally a far better cycle control. Combining this method with a new gestagen (Desogestrel) r …
[Effect of hormonal contraceptives containing 0.05 mg ethinyl estradiol and 0.125 mg desogestrel in normophasic regimen (Oviol)].
Weijers MJ. Weijers MJ. Fortschr Med. 1982 Apr 29;100(16):764-7. Fortschr Med. 1982. PMID: 6211403 Clinical Trial. German.
The contraceptive is a combination of an estrogen (ethinylestradiol) and a progestogen (desogestrel). It is designed to be used in 28-day cycles: 22 days of tablet-taking followed by 6 tablet-free days during which a withdrawal bleeding may normally be expected to occur. O …
The contraceptive is a combination of an estrogen (ethinylestradiol) and a progestogen (desogestrel). It is designed to be used in 28 …
Ovarian activity in women taking an oral contraceptive containing 20 microg ethinyl estradiol and 150 microg desogestrel: effects of low estrogen doses during the hormone-free interval.
Killick SR, Fitzgerald C, Davis A. Killick SR, et al. Am J Obstet Gynecol. 1998 Jul;179(1):S18-24. doi: 10.1016/s0002-9378(98)70292-3. Am J Obstet Gynecol. 1998. PMID: 9704814 Clinical Trial.
OBJECTIVE: We assessed the effect of low ethinyl estradiol doses given during the nominally hormone-free interval of the Mircette (brand of desogestrel/ethinyl estradiol and ethinyl estradiol) contraceptive regimen on ovarian activ …
OBJECTIVE: We assessed the effect of low ethinyl estradiol doses given during the nominally hormone-free interval of the Mirce …
Cycle control and side effects of a new combiphasic oral contraceptive regimen.
Dieben TO, op ten Berg MT, Coelingh Bennink HJ. Dieben TO, et al. Arzneimittelforschung. 1994 Jul;44(7):877-9. Arzneimittelforschung. 1994. PMID: 7945527 Clinical Trial.
The combiphasic preparation CTR 24 contains 25 micrograms desogestrel (CAS 54024-22-5) plus 40 micrograms ethinylestradiol (CAS 57-63-6) daily for the first 7 days followed by the combination of 125 micrograms desogestrel and 30 micrograms ethinyl-estradio …
The combiphasic preparation CTR 24 contains 25 micrograms desogestrel (CAS 54024-22-5) plus 40 micrograms ethinylestradiol (CAS 57-63 …
[Comparison of a 2-phase preparation (Oviol 22) with a low-dose 1-phase preparation (Ovoresta M)].
Dik M, Eckert H, Hönes S, Schindler AE. Dik M, et al. Geburtshilfe Frauenheilkd. 1984 Dec;44(12):808-12. doi: 10.1055/s-2008-1036524. Geburtshilfe Frauenheilkd. 1984. PMID: 6570117 German.
Oviol 22 was administered to 145, and Ovoresta M to 118 healthy female volunteers. During the first six cycles, 27 (18.6%) women discontinued the Oviol 22 intake, and 45 (38,1%) women discontinued the Ovoresta M intake. ...
Oviol 22 was administered to 145, and Ovoresta M to 118 healthy female volunteers. During the first six cycles, 27 (18.6%) women disc …
An open-label, multicenter, noncomparative safety and efficacy study of Mircette, a low-dose estrogen-progestin oral contraceptive. The Mircette Study Group.
[No authors listed] [No authors listed] Am J Obstet Gynecol. 1998 Jul;179(1):S2-8. doi: 10.1016/s0002-9378(98)70290-x. Am J Obstet Gynecol. 1998. PMID: 9704812 Clinical Trial.
OBJECTIVE: The primary efficacy and safety of Mircette (brand of desogestrel/ethinyl estradiol and ethinyl estradiol), an oral contraceptive containing 150 microg desogestrel and 20 microg ethinyl estradiol given for 21 days …
OBJECTIVE: The primary efficacy and safety of Mircette (brand of desogestrel/ethinyl estradiol and ethinyl es …
Multicentre study with a new biphasic oral contraceptive containing ethinylestradiol and desogestrel. Report on efficacy, cycle control and adverse experiences with special emphasis on blood pressure and weight.
Dieben TO, van Beek A, Coelingh Bennink HJ. Dieben TO, et al. Arzneimittelforschung. 1991 Sep;41(9):996-8. Arzneimittelforschung. 1991. PMID: 1839126 Clinical Trial.
The study period extended for 18 cycles. This biphasic OC contains 25 mcg desogestrel (CAS 54024-22-5) + 40 mcg ethinyl estradiol (CAS 57-63-6) daily for the 1st 7 days followed by a combination of 125 mcg desogestrel and 30 mcg ethinyl estra …
The study period extended for 18 cycles. This biphasic OC contains 25 mcg desogestrel (CAS 54024-22-5) + 40 mcg ethinyl est …
The consequences of exposure to mixtures of chemicals: Something from 'nothing' and 'a lot from a little' when fish are exposed to steroid hormones.
Thrupp TJ, Runnalls TJ, Scholze M, Kugathas S, Kortenkamp A, Sumpter JP. Thrupp TJ, et al. Sci Total Environ. 2018 Apr 1;619-620:1482-1492. doi: 10.1016/j.scitotenv.2017.11.081. Epub 2017 Dec 1. Sci Total Environ. 2018. PMID: 29734624 Free article.
Ill-defined, multi-component mixtures of steroidal pharmaceuticals are present in the aquatic environment. ...Further, when each component was present in the mixture at a concentration expected to inhibit egg production by between 18% (Beclomethasone diproprionate) …
Ill-defined, multi-component mixtures of steroidal pharmaceuticals are present in the aquatic environment. ...Further, when each comp …
34 results